sphingosine

sphingosine is a lipid of Sphingolipids (SP) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 26061 references associated with sphingosine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for sphingosine

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with sphingosine

Download all related citations
Per page 10 20 50 100 | Total 6563
Authors Title Published Journal PubMed Link
Chang N et al. Sphingosine 1-phosphate receptors negatively regulate collagen type I/III expression in human bone marrow-derived mesenchymal stem cell. 2014 J. Cell. Biochem. pmid:24038457
Das A et al. Delivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect. 2014 J Biomed Mater Res A pmid:23640833
Roviezzo F et al. Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate. 2014 Clin. Sci. pmid:24131465
Arya D et al. Sphingosine-1-phosphate promotes the differentiation of adipose-derived stem cells into endothelial nitric oxide synthase (eNOS) expressing endothelial-like cells. 2014 J. Biomed. Sci. pmid:24898615
Maceyka M and Spiegel S Sphingolipid metabolites in inflammatory disease. 2014 Nature pmid:24899305
Yamamoto R et al. ASP4058, a novel agonist for sphingosine 1-phosphate receptors 1 and 5, ameliorates rodent experimental autoimmune encephalomyelitis with a favorable safety profile. 2014 PLoS ONE pmid:25347187
Lu Z et al. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling. 2014 BMC Cancer pmid:25344679
Anderson G and Maes M Reconceptualizing adult neurogenesis: role for sphingosine-1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte-neuronal precursor interactions. 2014 CNS Neurol Disord Drug Targets pmid:24040808
Waeber C and Walther T Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction. 2014 Circ. J. pmid:24632793
Fragoso YD et al. The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis. 2014 Arq Neuropsiquiatr pmid:25252236
Sato DK and Callegaro D Oral fingolimod to treat multiple sclerosis: see your cardiologist first. 2014 Arq Neuropsiquiatr pmid:25252227
Bridel C and Lalive PH Update on multiple sclerosis treatments. 2014 Swiss Med Wkly pmid:25247669
Takeo T et al. Investigations of motility and fertilization potential in thawed cryopreserved mouse sperm from cold-stored epididymides. 2014 Cryobiology pmid:24201107
Muris AH et al. Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions. 2014 BMC Neurol pmid:25138918
Langeslag M et al. Sphingosine 1-phosphate to p38 signaling via S1P1 receptor and Gαi/o evokes augmentation of capsaicin-induced ionic currents in mouse sensory neurons. 2014 Mol Pain pmid:25431213
Blanc CA et al. FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination. 2014 J Neuroinflammation pmid:25138356
Callihan P et al. Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor. 2014 ASN Neuro pmid:25424429
Kułakowska A et al. Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitis. 2014 J Neuroinflammation pmid:25421616
Franklin MA et al. Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis. 2014 J Manag Care Spec Pharm pmid:25062072
Chen L et al. FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels. 2014 PLoS ONE pmid:25050888
Dai L et al. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy? 2014 Cancer Invest. pmid:24499107
Aliouane L et al. Synthesis of fluorinated agonist of sphingosine-1-phosphate receptor 1. 2014 Bioorg. Med. Chem. pmid:25047939
Dai Z and Green TK Synthesis of aromatic sphingosine analogues by diastereoselective amination of enantioenriched trans-γ,δ-unsaturated β-hydroxyesters. 2014 J. Org. Chem. pmid:25046474
Degagné E et al. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. 2014 J. Clin. Invest. pmid:25347472
Wang F and Ye P Improving heart function by modulating myocardiocyte autophagy: a possible novel mechanism for cardiovascular protection of high-density lipoprotein. 2014 Lipids Health Dis pmid:25339382
Keller J et al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts. 2014 Nat Commun pmid:25333900
Tao C et al. Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes. 2014 Best Pract. Res. Clin. Endocrinol. Metab. pmid:24417945
Hamidi S et al. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts. 2014 Biochim. Biophys. Acta pmid:24440818
Schaper K et al. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells. 2014 Mol. Immunol. pmid:24434636
Sasaki H et al. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway. 2014 Arch. Biochem. Biophys. pmid:24708996
Liu M et al. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. 2014 J. Biol. Chem. pmid:24318881
Huang YL et al. Extrinsic sphingosine 1-phosphate activates S1P5 and induces autophagy through generating endoplasmic reticulum stress in human prostate cancer PC-3 cells. 2014 Cell. Signal. pmid:24333325
Xiong Y et al. Erythrocyte-derived sphingosine 1-phosphate is essential for vascular development. 2014 J. Clin. Invest. pmid:25250575
Tan SJ et al. Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity. 2014 Reprod. Biomed. Online pmid:25246113
Rojas-Charry L et al. Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells. 2014 Neurotoxicology pmid:24792327
Nagahashi M et al. Sphingosine-1-phosphate transporters as targets for cancer therapy. 2014 Biomed Res Int pmid:25133174
Nguyen AV et al. STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer. 2014 World J. Gastroenterol. pmid:25132744
Kim ES et al. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression. 2014 Oncogene pmid:23955082
Thomas K et al. Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease. 2014 BMC Neurol pmid:24906818
Qian J et al. FTY720 attenuates paraquat-induced lung injury in mice. 2014 Int. Immunopharmacol. pmid:24893116
di Nuzzo L et al. Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. 2014 Drug Des Devel Ther pmid:24876766
Rolin J and Maghazachi AA Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis. 2014 J. Leukoc. Biol. pmid:24493826
Moon MH et al. Sphingosine-1-phosphate inhibits the adipogenic differentiation of 3T3-L1 preadipocytes. 2014 Int. J. Mol. Med. pmid:25050633
Wakashima T et al. Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation. 2014 J. Biol. Chem. pmid:25049234
Siciliano C et al. Synthesis of D-erythro-sphinganine through serine-derived α-amino epoxides. 2014 J. Org. Chem. pmid:24807867
Jiménez-Rojo N et al. Sphingosine induces the aggregation of imine-containing peroxidized vesicles. 2014 Biochim. Biophys. Acta pmid:24802275
Lima S et al. A real-time high-throughput fluorescence assay for sphingosine kinases. 2014 J. Lipid Res. pmid:24792926
Pippa R et al. Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity. 2014 Leukemia pmid:24781014
Rauch BH Sphingosine 1-phosphate as a link between blood coagulation and inflammation. 2014 Cell. Physiol. Biochem. pmid:24977491
Sattler K et al. HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis. 2014 Cell. Physiol. Biochem. pmid:24977490
Thuy AV et al. Sphingosine 1-phosphate in blood: function, metabolism, and fate. 2014 Cell. Physiol. Biochem. pmid:24977489
van Echten-Deckert G et al. Sphingosine-1-phosphate: boon and bane for the brain. 2014 Cell. Physiol. Biochem. pmid:24977488
Fayyaz S et al. Divergent role of sphingosine 1-phosphate on insulin resistance. 2014 Cell. Physiol. Biochem. pmid:24977487
Fukumoto K et al. Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment. 2014 Behav. Brain Res. pmid:24713151
Halmer R et al. Sphingolipids: important players in multiple sclerosis. 2014 Cell. Physiol. Biochem. pmid:24977485
Laroni A et al. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. 2014 BMC Neurol pmid:24690227
Tarbell JM et al. Mechanosensing at the vascular interface. 2014 Annu Rev Biomed Eng pmid:24905872
Potì F et al. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). 2014 Cardiovasc. Res. pmid:24891400
Chawla S et al. Exogenous sphingosine-1-phosphate boosts acclimatization in rats exposed to acute hypobaric hypoxia: assessment of haematological and metabolic effects. 2014 PLoS ONE pmid:24887065
Wollenberg A et al. Immunological and molecular targets of atopic dermatitis treatment. 2014 Br. J. Dermatol. pmid:24720588
Silveira-Dorta G et al. Direct stereoselective synthesis of enantiomerically pure anti-β-amino alcohols. 2014 J. Org. Chem. pmid:24708186
Bunn PT et al. Tissue requirements for establishing long-term CD4+ T cell-mediated immunity following Leishmania donovani infection. 2014 J. Immunol. pmid:24634490
Tanaka K et al. Individual profiles of free ceramide species and the constituent ceramide species of sphingomyelin and neutral glycosphingolipid and their alteration according to the sequential changes of environmental oxygen content in human colorectal cancer Caco-2 cells. 2014 Glycoconj. J. pmid:24310545
Kubota D et al. Proteomics identified overexpression of SET oncogene product and possible therapeutic utility of protein phosphatase 2A in alveolar soft part sarcoma. 2014 J. Proteome Res. pmid:24621013
Giovannoni G and Naismith RT Natalizumab to fingolimod washout in patients at risk of PML: when good intentions yield bad outcomes. 2014 Neurology pmid:24610331
Zhang GQ et al. Sphingosine-1-phosphate receptors respond differently to early myocardial ischemia and ischemia-reperfusion in vivo. 2014 Sheng Li Xue Bao pmid:24777407
Jokubaitis VG et al. Fingolimod after natalizumab and the risk of short-term relapse. 2014 Neurology pmid:24610329
Mahajan-Thakur S et al. Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes. 2014 J. Leukoc. Biol. pmid:24990321
Kondo S et al. Memo has a novel role in S1P signaling and is [corrected] crucial for vascular development. 2014 PLoS ONE pmid:24714781
Korbelik M et al. Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure. 2014 Int. Immunopharmacol. pmid:24713544
Gatfield J et al. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling. 2014 Cell. Signal. pmid:24704119
Zhang J and Song J Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate. 2014 Acta Biomater pmid:24631657
Priceman SJ et al. S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3. 2014 Cell Rep pmid:24630990
Wang G et al. The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction. 2014 J. Cardiovasc. Pharmacol. pmid:24508946
Sato DK et al. Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis. 2014 J. Neuroimmunol. pmid:24507619
Hagihara K et al. FTY720 stimulated ROS generation and the Sty1/Atf1 signaling pathway in the fission yeast Schizosaccharomyces pombe. 2014 Genes Cells pmid:24506481
Lu L et al. Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage. 2014 Brain Res. pmid:24502984
Mezzar S et al. RP-HPLC-fluorescence analysis of aliphatic aldehydes: application to aldehyde-generating enzymes HACL1 and SGPL1. 2014 J. Lipid Res. pmid:24323699
Swinnen E et al. The protein kinase Sch9 is a key regulator of sphingolipid metabolism in Saccharomyces cerevisiae. 2014 Mol. Biol. Cell pmid:24196832
Czubowicz K and Strosznajder R Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate. 2014 Mol. Neurobiol. pmid:24420784
Di Benedetto R et al. Protected sphingosine from phytosphingosine as an efficient acceptor in glycosylation reaction. 2014 Org. Lett. pmid:24428384
Pennisi E Ecology. Parasitic puppeteers begin to yield their secrets. 2014 Science pmid:24436399
Anthony DC et al. Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model. 2014 Neuropharmacology pmid:24412675
Chuang WL et al. Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients. 2014 Mol. Genet. Metab. pmid:24418695
Mendes-Braz M et al. The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. 2014 Liver Int. pmid:24107124
Buddaseth S et al. Overexpression of the pp32r1 (ANP32C) oncogene or its functional mutant pp32r1Y140H confers enhanced resistance to FTY720 (Finguimod). 2014 Cancer Biol. Ther. pmid:24335183
Voon V et al. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism. 2014 Eur. J. Clin. Pharmacol. pmid:24309839
Gold R et al. Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. 2014 J. Neurol. pmid:24221641
Wu YF et al. First total synthesis of ganglioside DSG-A possessing neuritogenic activity. 2014 Org. Biomol. Chem. pmid:25338766
Tuuf J and Mattjus P Membranes and mammalian glycolipid transferring proteins. 2014 Chem. Phys. Lipids pmid:24220498
Hutchinson M et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. 2014 Curr Med Res Opin pmid:24195574
Spinedi A Brefeldin A limits N-hexanoylsphingosine-induced accumulation of natural ceramide via the salvage pathway by enhancing glucosylation. 2014 Lipids pmid:24194457
Farhat M et al. Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases. 2014 Cell Death Dis pmid:24787013
Wang XQ et al. Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway. 2014 Prostaglandins Other Lipid Mediat. pmid:24614064
Kondo N et al. Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids. 2014 Nat Commun pmid:25345524
Fincher J et al. G-protein-coupled receptor cell signaling pathways mediating embryonic chick retinal growth cone collapse induced by lysophosphatidic acid and sphingosine-1-phosphate. 2014 Dev. Neurosci. pmid:25138637
Cencetti F et al. Lysophosphatidic acid stimulates cell migration of satellite cells. A role for the sphingosine kinase/sphingosine 1-phosphate axis. 2014 FEBS J. pmid:25131845
Francis G et al. Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy. 2014 Mult. Scler. pmid:23950550
Neuber C et al. Method to simultaneously determine the sphingosine 1-phosphate breakdown product (2E)-hexadecenal and its fatty acid derivatives using isotope-dilution HPLC-electrospray ionization-quadrupole/time-of-flight mass spectrometry. 2014 Anal. Chem. pmid:25137547
Nagahashi M et al. Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. 2014 Adv Biol Regul pmid:24210073